Details for New Drug Application (NDA): 070299
✉ Email this page to a colleague
NDA 070299 describes NALOXONE, which is a drug marketed by Hikma, Wyeth Ayerst, Abraxis Pharm, Accord Hlthcare, Astrazeneca, Baxter Hlthcare Corp, Bpi Labs, Chartwell Rx, Dr Reddys, Endo Operations, Eugia Pharma, Fresenius Kabi Usa, Hospira, Igi Labs Inc, Intl Medication, Mankind Pharma, Marsam Pharms Llc, Mylan Institutional, Mylan Labs Ltd, Par Sterile Products, Rising, Smith And Nephew, Solopak, Somerset Theraps Llc, Watson Labs, Amneal, Padagis Israel, Teva Pharms Usa, Kaleo Inc, Lupin, and Sun Pharm Inds Ltd, and is included in seventy-five NDAs. It is available from three suppliers. There are eighteen patents protecting this drug. Additional details are available on the NALOXONE profile page.
The generic ingredient in NALOXONE is naloxone hydrochloride; pentazocine hydrochloride. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride; pentazocine hydrochloride profile page.
The generic ingredient in NALOXONE is naloxone hydrochloride; pentazocine hydrochloride. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride; pentazocine hydrochloride profile page.
Summary for 070299
| Tradename: | NALOXONE |
| Applicant: | Hikma |
| Ingredient: | naloxone hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 070299
| Mechanism of Action | Opioid Antagonists |
Medical Subject Heading (MeSH) Categories for 070299
Suppliers and Packaging for NDA: 070299
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| NALOXONE | naloxone hydrochloride | INJECTABLE;INJECTION | 070299 | ANDA | Hikma Pharmaceuticals USA Inc. | 0641-6132 | 0641-6132-25 | 25 VIAL in 1 CARTON (0641-6132-25) / 1 mL in 1 VIAL (0641-6132-01) |
| NALOXONE | naloxone hydrochloride | INJECTABLE;INJECTION | 070299 | ANDA | Hikma Pharmaceuticals USA Inc. | 0641-6260 | 0641-6260-25 | 25 VIAL in 1 CARTON (0641-6260-25) / 1 mL in 1 VIAL (0641-6260-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.4MG/ML | ||||
| Approval Date: | Sep 24, 1986 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
